The Efficacy of Mepolizumab Treatment on Rhinovirus Induced Asthma Exacerbations.
Latest Information Update: 20 Nov 2023
Price :
$35 *
At a glance
- Drugs Mepolizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Acronyms MATERIAL
- 07 Sep 2018 Results published in the American Journal of Respiratory and Critical Care Medicine
- 07 Sep 2018 Status changed from recruiting to completed.
- 02 Jul 2013 New source identified and integrated: European Clincial Trials Database record.